Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer
Conditions : EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis Interventions : Drug: Sacituzumab tirumotecan Sponsors : Henan Cancer Hospital Not yet recruiting
Read the full article3d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Tampons Are Becoming a Valuable Medical Tool
reasonstobecheerful.world·27m ago
Avian flu arrives in New Zealand as global H5N1 outbreak continues to devastate bird populations
nzgeo.com·2h ago3D printing gets a living upgrade
Innovation News Network·2h ago
AI Drug Discovery Targets the Factory Floor
yesilscience.com·3h ago
Comprehensive study finds no link between mobile phones and brain cancer
theconversation.com·3h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.